Todd Wills

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. ncbi Elvitegravir: a once-daily inhibitor of HIV-1 integrase
    Todd Wills
    Division of Infectious Disease and International Medicine, University of South Florida College of Medicine, 1 Tampa General Circle, Tampa, FL, USA
    Expert Opin Investig Drugs 21:395-401. 2012

Detail Information

Publications1

  1. ncbi Elvitegravir: a once-daily inhibitor of HIV-1 integrase
    Todd Wills
    Division of Infectious Disease and International Medicine, University of South Florida College of Medicine, 1 Tampa General Circle, Tampa, FL, USA
    Expert Opin Investig Drugs 21:395-401. 2012
    ..Dolutegravir in development offers a favorable resistance profile and no requirement for pharmacologic boosting...